Demis Hassabis, DeepMind's founder and chief executive, has taken the same roles at Isomorphic Labs on an interim basis, saying in a blog post that the new company will "reimagine the entire drug ...

Isomorphic Labs has raised a whopping $600 million to ... The start-up – which has emerged from Google parent Alphabet's DeepMind project and is led by DeepMind founder Sir Demis Hassabis ...

In his dual capacity as the UK Government's AI Advisor and a DeepMind and Isomorphic Labs leader, Hassabis is not just defining the future of AI research but also shaping policy to ensure that AI ...

We must turn our attention to how AI's greatest strengths are dramatically improving innovation for creating real societal ...

Sir Demis Hassabis, co-founder of Google DeepMind and a knighted British AI pioneer, isn't breaking ground in AI or cracking the codes of protein structures, he's playing intellectual games like ...

One of the improvements in AlphaFold 3, which DeepMind made together with its drug-discovery spin-off Isomorphic Labs, is more-accurate structure predictions for protein and nucleic acid complexes.

Artificial intelligence is gaining ground in healthcare, and tech's biggest players are racing to stake their claims.

DeepMind's AlphaFold, a protein structure prediction AI system, has already made a substantial impact in biomedical research. Taking this forward, Hassabis established Isomorphic Labs, a drug ...